CROSS TIMBERS ROYALTY TRUST DECLARES NOVEMBER CASH DISTRIBUTION
DALLAS, Nov. 18, 2024 /PRNewswire/ -- Argent Trust Company, as Trustee of the Cross Timbers Royalty Trust (the "Trust") (NYSE: CRT),...
Month: November 2024
CopperCorp Intersects Broad Zones of Visible Copper Mineralization in Drilling at Jukes
Vancouver, British Columbia--(Newsfile Corp. - November 18, 2024) - CopperCorp Resources Inc. (TSXV: CPER) (OTCQB: CPCPF) ("CopperCorp" or the "Company")...
C3is Inc. reports third quarter and nine months 2024 financial and operating results
ATHENS, Greece, Nov. 18, 2024 (GLOBE NEWSWIRE) -- C3is Inc. (Nasdaq: CISS) (the “Company”), a ship-owning company providing dry bulk...
Beyond Oil Secures C$1.77 Million in Funding Through Warrant Exercises, Led by Strategic Partner West Coast Reduction
VANCOUVER, B.C. and KIBBUTZ YIFAT, ISRAEL , Nov. 18, 2024 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF)...
BridgeBio Pharma Announces Publication in the New England Journal of Medicine of Phase 2 PROPEL 2 Study of Infigratinib for Children Living with Achondroplasia
- In Cohort 5 of PROPEL 2, daily oral treatment of infigratinib at 0.25mg/kg resulted in statistically significant and sustained...
24/7 Market News Snapshot 18 November, 2024 – Vuzix Corporation (NASDAQ:VUZI)
DENVER, Colo., 18 November, 2024 (247marketnews.com) – (NASDAQ:VUZI) are discussed in this article. Vuzix Corporation (NASDAQ: VUZI) is currently experiencing...
Select Medical Holdings Corporation Announces Offering of $850 Million of Senior Notes by Select Medical Corporation
MECHANICSBURG, Pa., Nov. 18, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation ("Select")...
gkv informatik Selects Rezolve Ai’s Brain Suite to Drive Productivity and Innovation in the Healthcare Sector
NEW YORK and WUPPERTAL, Germany, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a leader in AI-driven solutions...
NOTICE TO SECURITYHOLDERS – NOVA CHEMICALS CORPORATION ANNOUNCES PROPOSED OFFERING OF $400 MILLION OF NEW SENIOR NOTES
CALGARY, AB, Nov. 18, 2024 /PRNewswire/ - NOVA Chemicals Corporation ("NOVA Chemicals") announced today that it intends to offer (the...
North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California
BISHOP, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- North Bay Resources Inc. (the “Company” or “North Bay”) (OTC: NBRI) is...
IKE Tech LLC and Ispire Technology Inc. Announce Positive Pre-PMTA Submission Meeting with the FDA
Seeks Authorization for Pioneering Point-of-Use Identity and Age Verification Technology to Reduce Youth Access and Expand the Adult Market for...
Intensity Therapeutics Presents INT230-6 Phase 1/2 Data in Sarcoma and an Overview of its Ongoing Global Randomized Phase 3 Sarcoma Trial (“INVINCIBLE-3 Study”) in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society Meeting (CTOS)
Phase 1/2 data showed a median overall survival ("mOS") of 21.3 months versus a synthetic control of 6.7 months, an...
Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives
NEWTOWN, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company...
Canoo Partners with Northside Truck & Van to Deliver its Initial Parts Network and Reliable Service, Maintenance, and Repair Services to Customers in the United Kingdom
JUSTIN, Texas and LONDON, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Canoo Inc. (Nasdaq: GOEV), a high-tech advanced mobility company, today...
FitLife Brands Responds to Investor Questions Regarding Registration Statement
OMAHA, NE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife,” or the “Company”) (Nasdaq: FTLF), a provider of...
First Phosphate annonce son inscription au marché OTCQB et l’éligibilité DTC aux États-Unis
Saguenay, Quebec--(Newsfile Corp. - 18 novembre 2024) - First Phosphate Corp. (CSE: PHOS) (OTCQB: FRSPF) (FSE: KD0) (« First Phosphate...
Fate Therapeutics Highlights FT522 Off-the-shelf, ADR-armed CAR NK Cell Product Candidate at 2024 ACR Convergence
Phase 1 Basket Study for B Cell-mediated Autoimmune Diseases to Assess FT522 as Add-on to Standard-of-care Induction and Maintenance Regimens...
Fate Therapeutics Presents 6-Month Follow-up Data on First Patient Treated in Phase 1 Autoimmunity Study with Fludarabine-free Conditioning and FT819 Off-the-shelf, 1XX CAR T-cell Product Candidate at ACR Convergence
27-year-old African American-Asian Woman with Active Lupus Nephritis Achieved DORIS Clinical Remission; Patient Remains On-study, in Clinical Remission, and Free...
TOYO Co., Ltd Updates on 2024 Performance, Announces Preliminary Guidance for 2025
TOKYO, Nov. 18, 2024 /PRNewswire/ -- TOYO Co., Ltd (Nasdaq: TOYO) ("TOYO" or the "Company"), a solar solution company, today provided...
Treasure Global Inc. Reports First Quarter Fiscal Year 2025 Financial Results
NEW YORK and KUALA LUMPUR, Malaysia, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or...
AtlasClear Holdings, Inc. Released 1st Quarter FY 2025 Financials
TAMPA, Fla.--(BUSINESS WIRE)--AtlasClear Holdings, Inc. (“AtlasClear Holdings”) (NYSE: ATCH) announced their financial results for the quarter ended September 30th, 2024,...
Sunrise Realty Trust Commits $13.0 Million in a Subordinate Loan for Excel Miami Apartments
WEST PALM BEACH, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Sunrise Realty Trust, Inc. (Nasdaq: SUNS) (“SUNS” or the “Company”)...
Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit
SOLANA BEACH, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on...
AmpliTech Group’s AmpliTech Inc. Division Secures Initial Purchase Order Under 5-Year Basic Order Agreement With Fortune 1000 U.S. Company
HAUPPAUGE, N.Y., Nov. 18, 2024 (GLOBE NEWSWIRE) -- AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of...
Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
Two patients exceed 14 months on treatment in Phase 2 trial of advanced ovarian cancerAllarity maintains a cash balance of...
Aclaris Therapeutics Announces $80 Million Private Placement
WAYNE, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS) (the “Company” or “Aclaris”), a clinical-stage biopharmaceutical...
Semler Scientific® Announces BTC and ATM Activity Raised $21.5 million; Purchased Additional 215 BTC; Now Holds 1,273 BTC with BTC Yield of 37.3%
SANTA CLARA, Calif., Nov. 18, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology...
Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders
Dual-action approach combining 5-HT4R Agonist (SPC-15) and NMDAR antagonist demonstrates enhanced efficacy in preclinical study for managing severe conditions The...
Sagimet Biosciences Presents Clinical Denifanstat and Preclinical FASN Inhibitor Data at AASLD – The Liver Meeting® 2024
Subset analysis of FASCINATE-2 Phase 2 trial demonstrated denifanstat improved fibrosis in difficult-to-treat MASH patients Both artificial intelligence (AI) and...
Rail Vision Unveils Innovative Active Control System, Enabling Semi-Autonomous Locomotive Capabilities
The system will be deployed as part of the initial rollout on the fleet of one of its leading U.S...
Phunware to Participate in the 13th Annual ROTH Technology Conference in New York City November 20, 2024
AUSTIN, Texas, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Phunware, Inc. (“Phunware” or the “Company”) (NASDAQ: PHUN), a leader in enterprise...
PERMIAN BASIN ROYALTY TRUST ANNOUNCES NOVEMBER CASH DISTRIBUTION AND EXCESS COST POSITION ON WADDELL RANCH PROPERTIES
DALLAS, Nov. 18, 2024 /PRNewswire/ -- Argent Trust Company, as Trustee of the Permian Basin Royalty Trust (NYSE: PBT) ("Permian" or...
24/7 Market News Snapshot 18 November, 2024 – Fate Therapeutics, Inc. (NASDAQ:FATE)
DENVER, Colo., 18 November, 2024 (247marketnews.com) – (NASDAQ:FATE) are discussed in this article. Fate Therapeutics, Inc. (NASDAQ: FATE), a leader...
24/7 Market News Snapshot 18 November, 2024 – Fate Therapeutics, Inc. (NASDAQ:FATE)
DENVER, Colo., 18 November, 2024 (247marketnews.com) – (NASDAQ:FATE) are discussed in this article. Fate Therapeutics, Inc. has experienced a significant...
24/7 Market News Snapshot 18 November, 2024 – Tuya Inc. American Depositary Shares, each representing one Class A Ordinary Share (NYSE:TUYA)
DENVER, Colo., 18 November, 2024 (247marketnews.com) – (NYSE:TUYA) are discussed in this article. Tuya Inc. is experiencing marked investor interest,...
NeuroBo Pharmaceuticals Announces Strategic Realignment Ahead of Important Clinical Milestones with Name Change to MetaVia – Reflecting the Company’s Focus on Cardiometabolic Diseases
New Nasdaq Ticker Symbol will be MTVA CAMBRIDGE, Mass., Nov. 18, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a...
24/7 Market News Snapshot 18 November, 2024 – Aclaris Therapeutics, Inc. (NASDAQ:ACRS)
DENVER, Colo., 18 November, 2024 (247marketnews.com) – (NASDAQ:ACRS) are discussed in this article. Aclaris Therapeutics, Inc. has captured the attention...
24/7 Market News Snapshot 18 November, 2024 – Aclaris Therapeutics, Inc. (NASDAQ:ACRS)
DENVER, Colo., 18 November, 2024 (247marketnews.com) – (NASDAQ:ACRS) are discussed in this article. Aclaris Therapeutics, Inc. (NASDAQ: ACRS) is experiencing...
Mega Matrix Announces that the Romantic Comedy Drama “Tears After ‘I Do'” to Be Launched on November 26
SINGAPORE, Nov. 18, 2024 /PRNewswire/ -- Mega Matrix Inc. ("MPU" or the "Company") (NYSE American: MPU), today announced that it...
MARA Holdings, Inc. Announces Proposed Private Offering of $700 Million of Convertible Senior Notes
Proceeds to be used primarily to acquire bitcoin, repurchase existing convertible notes due 2026 and for general corporate purposes Fort...